Table 2.
Comparative testing of commercially available DBM products.
| Reference | Animal model | Materials tested | Comments |
|---|---|---|---|
| Schwartz et al. [74] | Ectopic bone formation in nude mice | 14 lots of DBM from six different processors | Samples from three banks formed bone after 1 month and samples from two banks formed bone after 2 months. Samples from one bank failed to from new bone. |
| Bostrom et al. [47] | Ectopic bone formation in athymic rats | Grafton Dynagraft Osteofil, Opteform |
Toxicity associated with the glycerol carrier used in Grafton confounded the comparative analysis |
| Takikawa et al. [75] | Ectopic bone formation in athymic rats | Grafton Osteofil Rat DBM |
No significant differences in bone formation |
| Oakes et al. [76] | Femoral defects in athymic rats | Grafton DBX |
No significant differences in radiographic scores Endochondral ossification more prominent in DBX |
| Bomback et al [77] | Single level interprocess spinal fusions: athymic rats | Grafton OP-1 Autograft |
OP-1 promoted 100% fusion rates at 3 and 6 weeks while Grafton promoted 13% and 33% respectively. |
| Peterson et al. [78] | Spinal fusion in athymic rats | Grafton DBX Allomatrix |
Manual palpation after 8 weeks: 6 of 6 fusions for Grafton 3 of 6 fusions for DBX |
| Acarturk and Hollinger [79] | Critical sized defects in athymic rats | Allomatrix, DBM Grafton Dynagraft DBX Regenafil |
Statistically significant differences observed between DBM preparations; less new bone was observed with Allomatrix; Meshplate: Dynagraft; and Regenafil. |